Who and what is NEOGenomics?
The company, based in Fort Myers, is a premier cancer diagnostics company specializing in cancer genetics testing and oncology data solutions. They offer one of the most comprehensive oncology-focused testing menus across the cancer continuum.
They provide oncologists, pathologists, hospital systems, academic centers, and pharmaceutical and biotech firms with innovative diagnostic and predictive testing to help them diagnose and treat cancer.
Headquartered in Fort Myers, FL, NEOGenomics operates a network of CAP-accredited and CLIA-certified laboratories for full-service sample processing and analysis throughout the US and a CAP-accredited full-service, sample-processing laboratory in Cambridge, England, United Kingdom.
The company partners with healthcare providers to deliver advanced disease-state testing solutions that span all major methodologies, including next-generation sequencing (NGS) and broad-panel DNA and RNA testing, as well as a full complement of hematologic testing, to meet patients’ needs.
The company draws on one of the largest oncology databases, with over 2 million unique patient profiles. The operation harnesses data to facilitate the discovery and development of new therapeutic options, support clinical trial matching, and assess therapy outcomes, delivering personalized patient care.
The company partners with your oncology team to deliver advanced, multimodal solutions and validated methodologies. The company also maintains a dedicated team of MDs, PhDs, and project managers to optimize clinical outcomes and reduce treatment timelines.
NEOGenomics has integrated its oncology testing portfolio with Epic Aura, expanding access for physicians and health systems nationwide. The integration enables clinicians to order tests and view results within the Epic electronic health record workflow, streamlining care and supporting faster treatment decisions.
Officials have said the move could increase test adoption and improve the scalability of precision oncology services. The company provides cancer diagnostics and operates laboratories in the U.S. and internationally, supporting providers with comprehensive testing and analysis services.
Engage Estero is pleased to bring to your attention yet another highly advanced and specialized healthcare-focused company that, together with others like Southwest Proton, is enhancing the range and reputation of what is available on our doorstep!
Related Articles by Engage Estero
What is the value of Nanotechnology in Healthcare?
Where is it being used, and how does it impact health outcomes? Nanotechnology in healthcare refers to the use of extremely small materials, devices, or systems—typically on the scale of nanometers (1 to 100 nanometers -one nanometer is about as long as your...
Artificial Intelligence: Revolutionizing Healthcare Treatment Outcomes
In healthcare, the integration of Artificial Intelligence (AI) has become a powerful force with the potential to impact treatment outcomes significantly. AI's capacity to analyze large volumes of data, identify patterns, and make highly accurate predictions offers...
Written by
Allan Bowditch
President
Be Informed,
Get Engaged,
and Make an Impact!
At Engage Estero, we believe in the power of community. As a nonpartisan, nonpolitical, nonprofit, we conduct evidence-based research to provide unbiased information about local issues, helping you improve your quality of life.